Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-10-26

Clinical Trial Update: Reproducibility of Retinal Nerve Fiber Layer Thickness Measurements Using the Eye Tracker and Retest Function of Spectralis® SD-OCT in Glaucomatous Eyes and Healthy Controls [Phase 4]

View source ↗

Summary

This Phase 4 trial update assesses the reproducibility of retinal nerve fiber layer thickness measurements using the Eye Tracker and Retest function of Spectral…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Zurich | Conditions: Glaucoma | Phase 4 | Status: TERMINATED